Skip to content
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO

    North America

    Canada

    United States of America

    Latin AMerica

    Brazil

    Mexico

    Europe

    European Union

    Australia

    Australia

    Asia

    China

    Japan

    South Korea

    Taiwan

    Singapore

    India

  • Services

    Medical Devices

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Medical Writing
    • Health Authority Consultation
    • Clinical

    Pharmaceuticals

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Regulatory Operations
    • Health Authority Consultation

    Nutraceuticals / Food Supplements

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Verification of Nutrient Claims
    • Verification of Health Claims

    Cosmetics & Personal Care Products

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Cosmetic Packaging and Labeling Review
    • Product Classification and Formulation Review

    Pharmacovigilance

    • Overview
    • GRP Pharmacoviglance Services

    Quality

    • Preparation for FDA Inspections
    • GMP Mockup Quality Audits
    • ISO 13485 Quality Audits
    • GCP Audits
    • cGTP Audits
    • GAP Analysis Audits
    • Foreign Manufacture Accreditation (FMA)
    • QA SOPs Development
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)

    Japan

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    China

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Brazil

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Mexico

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    USA

    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
Home / Products / Page 5

“Mexico Regulation: Agreement of Prohibited and Permitted Plants That Are Determined For Teas, Infusions, Edible Vegetable Oils And Food Supplements.” has been added to your cart. View cart

Showing 65–80 of 155 results

  • Japan PMDA: Application for Marketing Authorization for Medical Devices in Japan

    Japan PMDA: Application for Marketing Authorization for Medical Devices in Japan

    $30.00
    Add to cart
  • Japan's PMDA: C-Reactive Protein Assay Kit Registration Technical Review Guideline

    Japan’s PMDA: C-Reactive Protein Assay Kit Registration Technical Review Guideline

    $100.00
    Add to cart
  • Labeling Standards for Drugs and Herbal Drugs in Mexico

    Labeling Standards for Drugs and Herbal Drugs in Mexico

    $75.00
    Add to cart
  • LIST OF PERMITTED ACTIVE INGREDIENTS IN COSMETIC HAIR PRODUCTS USED TO STRAIGHTEN OR CURL HAIR

    LIST OF PERMITTED ACTIVE INGREDIENTS IN COSMETIC HAIR PRODUCTS USED TO STRAIGHTEN OR CURL HAIR

    $50.00
    Add to cart
  • 000275204

    March 26, 2025 Office of New Drug II Pharmaceuticals and Medical Devices Agency

    $50.00
    Add to cart
  • Marketing Application - Home use MD for Diagnostic

    Marketing Application – Home use MD for Diagnostic

    Read more
  • Mexico Good Manufacturing Practices (GMP) for Medical Devices

    Mexico Good Manufacturing Practices (GMP) for Medical Devices

    $200.00
    Add to cart
  • Mexico Good Manufacturing Practices (GMP) Herbal Medicine and Remedies

    Mexico Good Manufacturing Practices (GMP) Herbal Medicine and Remedies

    $50.00
    Add to cart
  • Mexico Good Manufacturing Practices for Medicines (GMP)

    Mexico Good Manufacturing Practices for Medicines (GMP)

    $250.00
    Add to cart
  • Mexico Regulation:  Agreement Of Prohibited and Restricted Substances  Determined In The Production Of Perfumery And Beauty Products.

    Mexico Regulation: Agreement Of Prohibited and Restricted Substances Determined In The Production Of Perfumery And Beauty Products.

    $300.00
    Add to cart
  • Mexico Regulation: Agreement of Prohibited and Permitted Plants That Are Determined For Teas, Infusions, Edible Vegetable Oils And Food Supplements.

    Mexico Regulation: Agreement of Prohibited and Permitted Plants That Are Determined For Teas, Infusions, Edible Vegetable Oils And Food Supplements.

    $300.00
    Add to cart
  • Mexico's COFEPRIS: List of Additives and Coadjutants in Foods, Beverages and Food Supplements in Mexico

    Mexico’s COFEPRIS: List of Additives and Coadjutants in Foods, Beverages and Food Supplements in Mexico

    $200.00
    Add to cart
  • Mexico's Health Supplies Regulation

    Mexico’s Health Supplies Regulation

    $200.00
    Add to cart
  • MHLW-PFSB No. 0331002 :Timeline for New Drug Applications

    MHLW-PFSB No. 0331002 :Timeline for New Drug Applications

    $15.00
    Add to cart
  • Sale! Ministerial Ordinance 136: Standards for Quality Assurance for Drugs, Quasi-drugs, Cosmetics and Medical Devices

    Ministerial Ordinance 136: Standards for Quality Assurance for Drugs, Quasi-drugs, Cosmetics and Medical Devices

    $75.00 Original price was: $75.00.$60.00Current price is: $60.00.
    Add to cart
  • Sale! Ministerial Ordinance 161:  Good Clinical Practice  (GCP) for Drugs in Japan

    Ministerial Ordinance 161: Good Clinical Practice (GCP) for Drugs in Japan

    $200.00 Original price was: $200.00.$180.00Current price is: $180.00.
    Add to cart
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • →

ABOUT GRP GROUP

  • About US
  • Leadership
  • Why Choose Us

Useful Links

  • Contact Us
  • Brochures
  • Resource Center

GRP Headquarters (USA)

303 Wyman Street, Suite 300
Waltham, MA. 02451, USA
Tel : (+1 ) 781 - 672 -4200
Info@globalregulatorypartners.com

GRP Group Offices

  • GRP USA
  • GRP Japan
  • GRP China
  • GRP Korea
  • GRP Brazil
  • GRP Mexico

Follow Us on Social Media

Twitter Youtube Linkedin
  • Privacy Policy
  • Terms & Conditions
  • Cookies Policy
  • Other Policies

Copyright ©2023 Global Regulatory Partners

Contact Us!